Literature DB >> 30547142

Thyroid Stimulating Hormone (TSH)/Insulin-like Growth Factor 1 (IGF1) Receptor Cross-talk in Human Cells.

Christine C Krieger1, Sarah J Morgan1, Susanne Neumann1, Marvin C Gershengorn1.   

Abstract

Thyroid stimulating hormone and insulin-like growth factor 1 receptors (TSHRs and IGF1Rs, respectively) interact leading to additive or synergistic stimulation of cellular responses. Recent findings provide evidence that the interaction between TSHRs and IGF1Rs is similar to that described for other G protein-coupled receptors and receptor tyrosine kinases. These types of interactions occur at or proximal to the receptors and are designated "receptor cross-talk." Herein, we describe our studies in human thyrocytes, human retro-orbital fibroblasts from Graves' orbitopathy patients and a model cell line that support the concept of TSHR/IGF1R cross-talk. We also discuss how receptor cross-talk is involved in stimulation by a monoclonal TSHR-stimulating antibody and how targeting both receptors may lead to novel treatments of Graves' orbitopathy.

Entities:  

Keywords:  IGF1; TSH; receptor cross-talk

Year:  2018        PMID: 30547142      PMCID: PMC6287758          DOI: 10.1016/j.coemr.2018.01.007

Source DB:  PubMed          Journal:  Curr Opin Endocr Metab Res        ISSN: 2451-9650


  21 in total

Review 1.  GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation.

Authors:  Nicolas Delcourt; Joël Bockaert; Philippe Marin
Journal:  Trends Pharmacol Sci       Date:  2007-11-14       Impact factor: 14.819

2.  Thyrotropin and Insulin-Like Growth Factor 1 Receptor Crosstalk Upregulates Sodium-Iodide Symporter Expression in Primary Cultures of Human Thyrocytes.

Authors:  Sarah J Morgan; Susanne Neumann; Bernice Marcus-Samuels; Marvin C Gershengorn
Journal:  Thyroid       Date:  2016-10-18       Impact factor: 6.568

Review 3.  Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow?

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Trends Pharmacol Sci       Date:  2011-05-24       Impact factor: 14.819

Review 4.  Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.

Authors:  Terry J Smith; Laszlo Hegedüs; Raymond S Douglas
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

Review 5.  Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models.

Authors:  T Kimura; A Van Keymeulen; J Golstein; A Fusco; J E Dumont; P P Roger
Journal:  Endocr Rev       Date:  2001-10       Impact factor: 19.871

6.  Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I, as well as thyrotropin, in FRTL-5 thyroid cells.

Authors:  P Santisteban; L D Kohn; R Di Lauro
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

7.  Thyrotropin regulates autophosphorylation and kinase activity in both the insulin and the insulin-like growth factor-I receptors in FRTL5 cells.

Authors:  G Condorelli; P Formisano; C Miele; F Beguinot
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

8.  Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG.

Authors:  D Tramontano; G W Cushing; A C Moses; S H Ingbar
Journal:  Endocrinology       Date:  1986-08       Impact factor: 4.736

9.  TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis.

Authors:  Christine C Krieger; Robert F Place; Carmine Bevilacqua; Bernice Marcus-Samuels; Brent S Abel; Monica C Skarulis; George J Kahaly; Susanne Neumann; Marvin C Gershengorn
Journal:  J Clin Endocrinol Metab       Date:  2016-04-04       Impact factor: 5.958

10.  TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist.

Authors:  Hong Chen; Shannon J C Shan; Tünde Mester; Yi-Hsuan Wei; Raymond S Douglas
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

View more
  5 in total

1.  Inhibition of TSH/IGF-1 Receptor Crosstalk by Teprotumumab as a Treatment Modality of Thyroid Eye Disease.

Authors:  Christine C Krieger; Xiangliang Sui; George J Kahaly; Susanne Neumann; Marvin C Gershengorn
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

Review 2.  Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.

Authors:  Vardaan Gupta; Christine L Hammond; Elisa Roztocil; Mithra O Gonzalez; Steven E Feldon; Collynn F Woeller
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

3.  Thyroid-related ophthalmopathy development in concurrence with growth hormone administration.

Authors:  Shimpei Iwata; Kenji Tsumura; Kenji Ashida; Ichiro Tokubuchi; Mutsuyuki Demiya; Miyuki Kitamura; Hiroyuki Ohshima; Mamiko Yano; Ayako Nagayama; Junichi Yasuda; Munehisa Tsuruta; Seiichi Motomura; Shigeo Yoshida; Masatoshi Nomura
Journal:  BMC Endocr Disord       Date:  2021-08-19       Impact factor: 2.763

4.  Proximity ligation assay to study TSH receptor homodimerization and crosstalk with IGF-1 receptors in human thyroid cells.

Authors:  Christine C Krieger; Alisa Boutin; Susanne Neumann; Marvin C Gershengorn
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

Review 5.  Is There Evidence for IGF1R-Stimulating Abs in Graves' Orbitopathy Pathogenesis?

Authors:  Christine C Krieger; Susanne Neumann; Marvin C Gershengorn
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.